Women's Health Workshop
- Showcase the breadth and depth of women's health research at Purdue.
- Identify research gaps that can be readily addressed by leveraging Purdue's unique expertise and resources.
- Foster an interdisciplinary research community to enhance collaborations in women's health.
- Strategically position Purdue for upcoming funding opportunities under the White House Initiative on Women's Health Research.
Time: 2:30 - 5:00 PM, Nov 6, 2024
Location: DLR 131
Click here to view the full agenda
| 2:30 PM |
Welcome and opening remarks |
| 2:40 PM |
Short Talks (see featured speakers below) |
| 3:55 PM |
Intermission |
| 4:00 PM |
Breakout Sessions |
| 5:00 PM |
Conclusion |
Featured Speakers:
 |
"Effects of Chronic Hypertension on Cardiac Remodeling During Pregnancy"
Leslie A. Geddes Professor
Co-Director of Purdue Engineering Initiative in Engineering - Medicine
Director of Clinical Program, Weldon School of Biomedical Engineering
|
 |
"Computational Analysis of Clinical Routine Data for Medical Decision Support"
Research Assistant Professor
Weldon School of Biomedical Engineering
|
 |
"Creating Systems of Digitally-Enabled Care to Improve Maternal Outcomes"
Vincent P. Reilly Professor
Weldon School of Biomedical Engineering
|
 |
"Magnetic Resonance Spectroscopy in Women's Health and Mental Health"
Professor
School of Health Sciences
|
 |
"Sex-Dependent Molecular and Functional Changes in Neurons after Exposure"
Charles Davidson Professor
Chemical Engineering
|
 |
"Iron Status and Cognition During Perimenopause"
Professor and Department Head
Nutrition Science
|
 |
"Neurodevelopmental Disorders and Mental Health"
Associate Professor
Psychological Sciences
|
Breakout Sessions:
| Topic |
Lead |
Location |
|
|
|
DLR 131 (front left of the room) |
Neurodegenerative Disorders
|
|
DLR131(center for the room) |
Mental Health and Well-being
|
|
DLR131(back right of theroom) |
|
|
|
DLR Atrium (near the main entrance) |
|
|
Laura Murray-Kolb |
DLR Atrium (opposite the main entrance) |
Women's Cancers and Cancer Disparities
|
|
DLR134A |
Exposure and Sex Differences
|
|
DLR221 |
Addiction and Substance Use Disorder
|
Julia Chester |
DLR203A |
|
|
|
DLR423 |
Funding Opportunities on Women's Health
Alzheimer's Disease
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Neurodegenerative Disorders
Notice of Special Interest (NOSI): Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Mental Health and Well-being
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
Request for Information (RFI): Future Directions in Violence Against Women Research
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Notice of Special Interest (NOSI): Interventions to promote mental well-being in populations that experience health disparities through social, cultural, and environmental connectedness
Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Cardiovascular Health
Notice of Special Interest (NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health Disparities
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Menopause and Aging
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Women's Cancers and Cancer Disparities
Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)
NLM Information Resource Grants to Reduce Health Disparities and Promote Health Equity (G08 Clinical Trial Not Allowed)
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Exposure and Sex Differences
Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable
Notice of Special Interest (NOSI): Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Climate Change and Health
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Notice Announcing Availability of Data Harmonization Tools for Social Determinants of Health (SDOH) via the PhenX Toolkit
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Addiction and Substance Use Disorder
Notice of Special Interest (NOSI): Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Musculoskeletal Health
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Other
Notice of Special Interest: R13 Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements
Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum
Melinda French Gates organization --- Action for Women’s Health: $250 million global open call
Notice of Special Interest (NOSI): Advancing Research on Early Pregnancy Loss
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative
NIH launches $3 million prize competition to modernize diagnosis of endometriosis
Multisite Clinical Research: Leveraging Network Infrastructure to Advance Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (U01 Clinical Trial Optional)
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health
Request for Information: Prioritization of Drug, Vaccine, and Dietary Supplement Research Needs for Pregnant, Postpartum, and Lactating Persons
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed)
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
White House Initiative on Women’s Health Research
NIH Notice of Special Interest: Women's Health Research
NSF: Funding Opportunities for Science and Engineering Research with Impact on Women's Health
NIH-Wide Strategic Plan for Research on the Health of Women
